# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-015679
Filing Date
2024-05-09
Accepted
2024-05-09 16:11:46
Documents
92
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | nby20240331_10q.htm iXBRL | 10-Q | 1852798
2 | EXHIBIT 31.1 | ex_664757.htm | EX-31.1 | 7881
3 | EXHIBIT 31.2 | ex_664758.htm | EX-31.2 | 8213
4 | EXHIBIT 32.1 | ex_664759.htm | EX-32.1 | 3905
5 | EXHIBIT 32.2 | ex_664760.htm | EX-32.2 | 3886
| Complete submission text file | 0001437749-24-015679.txt |  | 10687632

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | nby-20240331.xsd | EX-101.SCH | 93423
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nby-20240331_cal.xml | EX-101.CAL | 54859
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nby-20240331_def.xml | EX-101.DEF | 590434
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nby-20240331_lab.xml | EX-101.LAB | 504346
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nby-20240331_pre.xml | EX-101.PRE | 632828
96 | EXTRACTED XBRL INSTANCE DOCUMENT | nby20240331_10q_htm.xml | XML | 2225658

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 24930715
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)